GlobeNewswire

Bermuda's global business sector showcased in London

Dela

HAMILTON, Bermuda, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Leaders of Bermuda's global business sector highlighted the breadth, advantages and significant economic impact of the island's financial market during an awareness-raising cross-industry forum held in London today by the Bermuda Business Development Agency (BDA).

Photos accompanying this announcement are available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/2bcaa95b-e3ca-44c9-899a-cb70eeb4cf10 
http://www.globenewswire.com/NewsRoom/AttachmentNg/7bdeef31-44cc-4e6d-9984-f08a6cd6bfe7 
http://www.globenewswire.com/NewsRoom/AttachmentNg/edb31e57-95aa-4327-8abb-47277d9619a2

Premier the Hon David Burt officially opened the day-long forum after meeting with Britain's Prime Minister Theresa May. The Premier is in the city for the BDA event as well as annual Joint Ministerial Council (JMC) meetings and various Parliamentary events, followed by planned visits to Paris and Berlin later in the week.

"Our government supports events like this BDA forum, because it's important to engage people from around the world to help accomplish our goals growing Bermuda's economy," said the Premier. "Bermuda has a very powerful story to tell as a well-regarded international financial centre known for robust regulation and leadership on transparency and compliance. We believe this is an excellent platform to talk about Bermuda's role in supporting global economies. It's important, because we trade on that reputation."

The forum attracted close to 250 delegates, encompassing a wide range of industries, to ME London Hotel in the city's West End. Featuring top regulatory and industry representatives in discussion panels, the agenda covered hot-button topics such as Brexit and the recent theft of "Paradise Papers" law-firm data, while emphasising the many elements that differentiate Bermuda-from the island's world-respected regulator and access to capital to its deep pool of valuable industry expertise. Speakers also examined the varied sectors that make Bermuda a centre of excellence, including re/insurance, captive insurance and insurance-linked securities, to asset management, family offices, and trust and private-client business.

"The forum has provided us with an opportunity to tell the Bermuda story at a critical juncture when the European spotlight is on international financial centres," said BDA CEO Ross Webber. "Our jurisdiction has a compelling message, and people are beginning to understand that Bermuda really is different."

Forum panels in the morning covered risk-industry topics-from insurance trends and the outlook for 2018 to why Bermuda remains "the World's Risk Capital." Afternoon sessions focused on the rapidly-growing convergence of re/insurance and asset management, then moved to examine high-net-worth services, family governance and charitable trust structuring.

The day's line-up featured 25 Bermuda executives, including Bermuda Monetary Authority CEO Jeremy Cox; Bermuda Stock Exchange CEO Greg Wojciechowski; Association of Bermuda Insurers & Reinsurers President Brad Kading; Grainne Richmond, President of the Bermuda Insurance Management Association (BIMA); and Keith Robinson, Chairman of the Society of Trust & Estate Practitioners (STEP) Bermuda.

Keynote speaker, Deputy Chair of Lloyd's and Hiscox Chair Robert Childs, described Bermuda's speed to market and detailed the many advantages Bermuda had lent to Hiscox.

"The forum gathered government, industry and regulatory experience to give attendees an opportunity to be exposed to the Bermuda market," said BMA CEO Jeremy Cox. "That kind of collaboration is part of what has made Bermuda successful. Certainly, given the times we're in, that's important-because there's been a lot of misinformation in the media about our jurisdiction. This has given us an opportunity to set the record straight."

Other Bermuda-based executive participants included Mark Allitt of KPMG Bermuda; Sarah Demerling of Estera; BDA former chair and Hiscox Director Caroline Foulger; David Gibbons of PwC Bermuda; Ed Granski for Meritus Trust; Randall Krebs of Harbour International Trust Company; BDA Board member Jessel Mendes, of EY Bermuda; Michael Neff of Butterfield Bank; Michael Parrish of Marsh Bermuda; Peter Pearman of Conyers Dill & Pearman; Brian Quinn of Granite Management; Fozeia Rana-Fahy of MJM; Aon CEO Joe Rego; Andrew Smith of Qatar Re; Ariane West of Taylors in association with Walkers; Arthur Wightman of PwC Bermuda; Kim Willey of ASW Law; and Akilah Wilson of the BMA.

"We were very impressed by the support not just from Bermuda industry but from friends of Bermuda here in the UK," Webber added. "We had over 20 different companies represented at our forum; that's a marvellous endorsement of the work of the BDA, and a great reflection of the collaboration of the Bermuda market. It's very rewarding to see Bermuda so well represented and supported."

Overseas presenters included Richard Hay of Stikeman Elliott, London; Siân Hill of KPMG UK; and Samantha Morgan of RMW Law.

"It's about working relationships with the right people - we're not just marketing the jurisdiction," said Jessel Mendes, a BDA Board member and Partner at EY Bermuda. "We're really selling, and I think that's critical. It's about working the relationships with the right people to bring business back to Bermuda. Today, the focus is on the relationship, on business development, and on sales. That's a new mindshift and I believe credit for it goes to the BDA."

Tomorrow, a second industry event-"Beyond Convergence"-will also take place at the hotel, focusing solely on insurance-linked securities. Organised by ILS Bermuda to dovetail with today's forum, it will provide a more detailed look at Bermuda's success in attracting capital, expertise and clients to the sphere of alternative reinsurance. Featured speakers will include some of the same industry executives, including the BSX's Wojciechowski, the BMA's Cox, ABIR's Kading, and BDA's Webber.

MEDIA CONTACT:
Rosemary Jones
Head of Communications & Marketing
rosemary@bda.bm 441 278-6558
441 337-4696

CONNECTING BUSINESS

The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bermuda Business Development Agency (BDA) via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum